Literature DB >> 21491338

The psychological impact of facial changes in scleroderma.

Kavit Amin1, A Clarke, B Sivakumar, A Puri, Z Fox, V Brough, C P Denton, E M Peter, P Butler, M D Butler.   

Abstract

The physical disabilities associated with scleroderma are well known but the psychological impact of the condition has received less attention. Few studies have examined appearance related issues, most notably of the face. The aim of this study is to evaluate the psychological impact of facial, aesthetic and functional changes in scleroderma. One hundred seventy-one patients with a clinical diagnosis of scleroderma were recruited into the study. Digital photographs were objectively graded into groups based on severity of disfigurement as judged by an observer. Facial movement was recorded using a modified House-Brackmann Grading Scale. Psychological evaluation comprised the Derriford Appearance Scale short-form (DAS), the Noticeability and Worry score and the Hospital Anxiety and Depression Scale (HADS). Severity of disfigurement predicted decreased mouth opening, the extent to which participants judged their appearance as noticeable to others, and the level of appearance-related concern as measured by the DAS24. There was an inverse relationship with age. Facial changes were ranked as the most worrying aspect of the condition. This study shows facial disfigurement impacts on patient with scleroderma independent of functional changes related to systemic disease. The major difficulty is with the perceived noticeably of the condition to other people and the resulting self-consciousness in social encounters.
© 2011 Taylor & Francis

Entities:  

Mesh:

Year:  2011        PMID: 21491338     DOI: 10.1080/13548506.2010.540250

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  15 in total

Review 1.  My approach to the treatment of scleroderma.

Authors:  Ami A Shah; Fredrick M Wigley
Journal:  Mayo Clin Proc       Date:  2013-04       Impact factor: 7.616

2.  Malnutrition, associated clinical factors, and depression in systemic sclerosis: a cross-sectional study.

Authors:  İpek Türk; Nihan Cüzdan; Volkan Çiftçi; Didem Arslan; Muharrem Cem Doğan; İlker Unal
Journal:  Clin Rheumatol       Date:  2019-05-26       Impact factor: 2.980

3.  Factors related to alexithymia in patients with systemic sclerosis: a tight relationship with facial image dissatisfaction.

Authors:  Fabio Basta; Domenico Paolo Emanuele Margiotta; Carmen Mazzuca; Veronica Batani; Giulio Dolcini; Patrizio Moras; Marta Vadacca; Antonella Afeltra
Journal:  Rheumatol Int       Date:  2018-11-29       Impact factor: 2.631

4.  Correlations Between Clinical Features and Mouth Opening in Patients With Systemic Sclerosis.

Authors:  İpek TÜrk; Nihan CÜzdan; Volkan ÇİftÇİ; Didem Arslan; İlker Ünal
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

5.  Development and Validation of the Body Concealment Scale for Scleroderma.

Authors:  Lisa R Jewett; Vanessa L Malcarne; Linda Kwakkenbos; Diana Harcourt; Nichola Rumsey; Annett Körner; Russell J Steele; Marie Hudson; Murray Baron; Jennifer A Haythornthwaite; Leslie Heinberg; Fredrick M Wigley; Brett D Thombs
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-08       Impact factor: 4.794

6.  Risk association between scleroderma disease characteristics, periodontitis, and tooth loss.

Authors:  Gaetano Isola; Ray C Williams; Alberto Lo Gullo; Luca Ramaglia; Marco Matarese; Vincenzo Iorio-Siciliano; Claudio Cosio; Giovanni Matarese
Journal:  Clin Rheumatol       Date:  2017-10-07       Impact factor: 2.980

7.  Sociodemographic and disease correlates of body image distress among patients with systemic sclerosis.

Authors:  Lisa R Jewett; Marie Hudson; Vanessa L Malcarne; Murray Baron; Brett D Thombs
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

Review 8.  Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS).

Authors:  Henrik Pettersson; Helene Alexanderson; Janet L Poole; Janos Varga; Malin Regardt; Anne-Marie Russell; Yasser Salam; Kelly Jensen; Jennifer Mansour; Tracy Frech; Carol Feghali-Bostwick; Cecília Varjú; Nancy Baldwin; Matty Heenan; Kim Fligelstone; Monica Holmner; Matthew R Lammi; Mary Beth Scholand; Lee Shapiro; Elizabeth R Volkmann; Lesley Ann Saketkoo
Journal:  Best Pract Res Clin Rheumatol       Date:  2021-07-01       Impact factor: 4.991

9.  The Help of Hypnodontics to a Patient With Scleroderma ‒ Case Report.

Authors:  Mohsen Ramazani; Nafiseh Zarenejad; Kaveh Ebrahimi
Journal:  Iran J Psychiatry Behav Sci       Date:  2015-03-20

10.  Exploring Sources of Emotional Distress among People Living with Scleroderma: A Focus Group Study.

Authors:  Stephanie T Gumuchian; Sandra Peláez; Vanessa C Delisle; Marie-Eve Carrier; Lisa R Jewett; Ghassan El-Baalbaki; Catherine Fortune; Marie Hudson; Ann Impens; Annett Körner; Jennifer Persmann; Linda Kwakkenbos; Susan J Bartlett; Brett D Thombs
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.